NASDAQ
14.47USD
-0.55 (-3.66%)
Dots are scored news catalysts — size = impact, color = sentiment. Tap one to read it.
Market cap
399M
P/E
—
EPS
—
Beta
1.19
52W range
8.72-27.41
Day range
13.99–15.32
Open
15.14
Prev close
15.02
Volume
291.1K
Avg volume
364.4K
Dividend
0.00
IPO
2014-01-10
https://www.globenewswire.com/news-release/2026/07/30/3335951/0/en/crescent-biopharma-reports-second-quarter-2026-financial-results-and-recent-business-highlights.html · 7/30/2026+0.80
https://www.globenewswire.com/news-release/2026/07/15/3327429/0/en/Crescent-Biopharma-Announces-Pricing-of-Public-Offering-of-Ordinary-Shares-and-Pre-Funded-Warrants.html · 7/15/2026+0.40
https://www.globenewswire.com/news-release/2026/01/30/3229772/0/en/Crescent-Biopharma-Announces-Grants-of-Inducement-Awards.html · 1/30/2026+0.00
https://www.globenewswire.com/news-release/2025/11/17/3189590/0/en/Crescent-Biopharma-Announces-Grants-of-Inducement-Awards.html · 11/17/2025+0.10
Crescent Biopharma, Inc. is a biotechnology firm dedicated to the research and development of novel cancer therapies. Its investigational portfolio notably includes CR-001, a proprietary bispecific antibody engineered to simultaneously target PD-1 and VEGF pathways for the treatment of solid tumors. The company's pipeline further comprises CR-002 and CR-003. Crescent Biopharma also maintains a strategic alliance with Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd., focusing on the joint advancement and commercialization of oncology therapeutics, encompassing innovative combination approaches. The company's operations are headquartered in Waltham, Massachusetts.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
